SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 93 filers reported holding SAGE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,000 | -69.8% | 416 | -29.1% | 0.00% | -75.0% |
| Q1 2021 | $43,000 | +186.7% | 587 | +10.1% | 0.00% | -60.0% |
| Q1 2020 | $15,000 | -86.1% | 533 | -30.9% | 0.01% | -9.1% |
| Q3 2019 | $108,000 | +315.4% | 771 | +303.7% | 0.01% | +450.0% |
| Q3 2018 | $26,000 | -70.1% | 191 | -82.7% | 0.00% | -75.0% |
| Q2 2017 | $87,000 | -8.4% | 1,102 | -18.2% | 0.01% | -20.0% |
| Q1 2017 | $95,000 | -10.4% | 1,348 | -35.4% | 0.01% | -16.7% |
| Q4 2016 | $106,000 | +21.8% | 2,088 | -27.9% | 0.01% | +33.3% |
| Q2 2016 | $87,000 | -25.0% | 2,895 | -20.5% | 0.01% | -52.6% |
| Q1 2016 | $116,000 | +4.5% | 3,640 | +90.2% | 0.02% | 0.0% |
| Q4 2015 | $111,000 | +105.6% | 1,914 | +48.4% | 0.02% | +111.1% |
| Q3 2015 | $54,000 | – | 1,290 | +16025.0% | 0.01% | – |
| Q2 2015 | $0 | -100.0% | 8 | -99.3% | 0.00% | -100.0% |
| Q1 2015 | $60,000 | – | 1,199 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |